When Mangenda Kamara became pregnant as a teenager in Sierra Leone, her community and secondary school teachers made her feel ...
The 2024 Lancet Commission on dementia prevention, intervention, and care1 provided unprecedented scientific clarity and public health impetus by identifying 14 modifiable risk factors and estimating ...
We would like to thank Agustin Ibanez and Hernando Santamaria-Garcia for their positive comments and agree with them that it is important to build on the 2024 Lancet Commission on dementia prevention, ...
Anthony Fauci's US senate committee hearings were a chilling political circus. Fauci, the 85-year-old retired Director of the National Institute of Allergy and Infectious Diseases (NIAID; part of the ...
OP investigators1 should be congratulated for their foresight in anticipating the biologically plausible benefits of integrating immunotherapy into the curative-intent treatment setting for head and ...
Between August, 2025, and July, 2026, US state legislatures considered more than 400 vaccine-related bills, of which 209 sought to weaken vaccination rules, systems, or public confidence; only nine ...
Dementia prevention is a global health priority. The 2024 update of the Lancet Commission on dementia estimated that 14 modifiable risk factors account for up to 45% of dementia cases, with 3% of ...
The past decade has seen many advances in the treatment of haematological malignancies, particularly with the rise of ...
From constructing cell-like systems to creating genomes from scratch, synthetic biology is having a moment. What will it mean ...
A 92-year-old man with a history of diffuse large B-cell lymphoma treated with chemoradiotherapy, and later with radiotherapy for an isolated cutaneous relapse with complete response, presented with a ...
Witness testimony by Ukrainian prisoners of war describes how medical staff participated in or enabled mistreatment. Ed Holt reports.
Can a modest increase in radiotherapy dose make a difference for a patient with high-risk prostate cancer? In The Lancet Oncology, Christophe Hennequin and colleagues present results from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results